3 March 2008

Ellex Appoints Tony Mitchell as CFO

Adelaide, Australia, 3 March 2008 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, announced today the appointment of Tony Mitchell as CFO and Company Secretary.

Mr. Mitchell brings more than twenty years of experience in senior financial and operational management to Ellex. Most recently he held the positions of CFO and Company Secretary for five years with GroPep Limited, an Adelaide based, ASX listed, biotechnology company. Prior to this, he held various senior roles within Faulding and Mayne Pharma, including VP Finance of the pharmaceutical division.

Kevin McGuinness, who joined Ellex as CFO in 2002 and was appointed COO in April 2006, will focus on COO responsibilities. Commenting on the appointment, Mr. Peter Falzon, CEO, said “We are pleased to have Tony joining Ellex. He brings considerable senior financial management experience and as a member of our Executive Management Team, will play a key role as we develop and implement our growth strategies.” Mr. Mitchell will joins Ellex from today.

ABOUT ELLEX

Ellex Medical Lasers Limited (ASX:ELX) designs, manufactures and markets a complete line of lasers and diagnostic ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. With more than 14,000 systems delivered to the market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan and Australia, and a network of distribution partners in more than 100 countries. In December 2006 Ellex acquired Innovative Imaging, a leading provider of diagnostic ultrasound devices for ophthalmology, initiating the expansion of its product line beyond lasers. Ellex maintains a strong emphasis on intellectual property and research into new and better treatments to manage and treat the leading causes of blindness.